Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Effects of rasagiline on freezing of gait in Parkinson's disease - an open-label, multicenter study

F. Cibulcik, J. Benetin, E. Kurca, M. Grofik, M. Dvorak, D. Richter, V. Donath, J. Kothaj, M. Minar, P. Valkovic

. 2016 ; 160 (4) : 549-552. [pub] 20160421

Language English Country Czech Republic

Document type Clinical Trial, Journal Article, Multicenter Study

Persistent link   https://www.medvik.cz/link/bmc17016699

AIMS: Freezing of gait is a disabling symptom in advanced Parkinson's disease. Positive effects have been suggested with MAO-B inhibitors. We report on an open label clinical study on the efficacy of rasagiline as add-on therapy on freezing of gait and quality of life in patients with Parkinson's disease. METHODS: Forty two patients with freezing of gait were treated with 1 mg rasagiline daily as an add-on therapy. Patients were assessed at baseline and after 1, 2 and 3 months of treatment. Freezing of gait severity was assessed using the Freezing of Gait Questionnaire, motor impairment by the modified MDS UPDRS part III, and quality of life using the PDQ-39 questionnaire. RESULTS: Patients treated with rasagiline had a statistically significant decrease in FoG-Q score and modified MDS UPDRS score after 1, 2 and 3 months of therapy. A moderately strong (r = 0.686, P = 0.002) correlation between the effects on mobility and freezing of gait was found. We also observed a statistically significant improvement in global QoL and in the subscales mobility, ADL, stigma and bodily discomfort in patients after 3 months of rasagiline therapy. A significant correlation (r = 0.570, P = 0.02) between baseline FoG-Q score and the baseline score for the PDQ Mobility subscale was found. CONCLUSION: In our study rasagiline as add-on antiparkinsonian therapy significantly improved mobility, freezing of gait and quality of life. The positive effect on freezing of gait appears to be related to improvement of mobility.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17016699
003      
CZ-PrNML
005      
20170519133914.0
007      
ta
008      
170516s2016 xr f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2016.023 $2 doi
035    __
$a (PubMed)27108605
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Cibulčík, František $u Department of Neurology, Faculty of Medicine, Slovak Medical University in Bratislava and University Hospital Bratislava, Slovak Republic $7 xx0106477
245    10
$a Effects of rasagiline on freezing of gait in Parkinson's disease - an open-label, multicenter study / $c F. Cibulcik, J. Benetin, E. Kurca, M. Grofik, M. Dvorak, D. Richter, V. Donath, J. Kothaj, M. Minar, P. Valkovic
520    9_
$a AIMS: Freezing of gait is a disabling symptom in advanced Parkinson's disease. Positive effects have been suggested with MAO-B inhibitors. We report on an open label clinical study on the efficacy of rasagiline as add-on therapy on freezing of gait and quality of life in patients with Parkinson's disease. METHODS: Forty two patients with freezing of gait were treated with 1 mg rasagiline daily as an add-on therapy. Patients were assessed at baseline and after 1, 2 and 3 months of treatment. Freezing of gait severity was assessed using the Freezing of Gait Questionnaire, motor impairment by the modified MDS UPDRS part III, and quality of life using the PDQ-39 questionnaire. RESULTS: Patients treated with rasagiline had a statistically significant decrease in FoG-Q score and modified MDS UPDRS score after 1, 2 and 3 months of therapy. A moderately strong (r = 0.686, P = 0.002) correlation between the effects on mobility and freezing of gait was found. We also observed a statistically significant improvement in global QoL and in the subscales mobility, ADL, stigma and bodily discomfort in patients after 3 months of rasagiline therapy. A significant correlation (r = 0.570, P = 0.02) between baseline FoG-Q score and the baseline score for the PDQ Mobility subscale was found. CONCLUSION: In our study rasagiline as add-on antiparkinsonian therapy significantly improved mobility, freezing of gait and quality of life. The positive effect on freezing of gait appears to be related to improvement of mobility.
650    _2
$a senioři $7 D000368
650    _2
$a analýza rozptylu $7 D000704
650    _2
$a antiparkinsonika $x aplikace a dávkování $7 D000978
650    _2
$a rozvrh dávkování léků $7 D004334
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a neurologické poruchy chůze $x farmakoterapie $7 D020233
650    _2
$a lidé $7 D006801
650    _2
$a indany $x aplikace a dávkování $7 D007189
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a Parkinsonova nemoc $x farmakoterapie $7 D010300
650    _2
$a kvalita života $7 D011788
650    _2
$a průzkumy a dotazníky $7 D011795
650    _2
$a výsledek terapie $7 D016896
655    _2
$a klinické zkoušky $7 D016430
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Benetin, Ján $u Department of Neurology, Faculty of Medicine, Slovak Medical University in Bratislava and University Hospital Bratislava, Slovak Republic $7 xx0140825
700    1_
$a Kurča, Egon, $u Department of Neurology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin and University Hospital Martin, Slovak Republic $d 1964- $7 nlk20050162662
700    1_
$a Grofik, Milan $u Department of Neurology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin and University Hospital Martin, Slovak Republic $7 xx0138028
700    1_
$a Dvorák, Miloslav $u Department of Neurology, Hospital Spisska Nova Ves, Slovak Republic $7 xx0244020
700    1_
$a Richter, Denis $u Department of Neurology, University Hospital Bratislava, Slovak Republic $7 _AN029956
700    1_
$a Donáth, Vladimír, $u Department of Neurology, Slovak Health University, Roosevelt Hospital Banska Bystrica, Slovak Republic $d 1949- $7 xx0063678
700    1_
$a Kothaj, J. $u Department of Neurology, Slovak Health University, Roosevelt Hospital Banska Bystrica, Slovak Republic $7 _AN044105
700    1_
$a Minár, Michal $u Second Department of Neurology, Faculty of Medicine, Comenius University in Bratislava, Slovak Republic $7 xx0233961
700    1_
$a Valkovič, Peter $u Second Department of Neurology, Faculty of Medicine, Comenius University in Bratislava, Slovak Republic $7 xx0107011
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 160, č. 4 (2016), s. 549-552
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20170516 $b ABA008
991    __
$a 20170517142121 $b ABA008
999    __
$a ok $b bmc $g 1205839 $s 977508
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 160 $c 4 $d 549-552 $e 20160421 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20170516

Find record

Citation metrics

Archiving options